institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Nerve Pain Medication Gabapentin Possibly Tied to Dementia, Study Says

UNITED STATES, JUL 11 – A large US study found adults aged 35-64 prescribed gabapentin had over twice the risk of dementia, with risk increasing alongside prescription frequency, researchers said.

  • On July 10, the journal Regional Anesthesia & Pain Medicine published a large observational study, drawing on TriNetX network data, linking frequent gabapentin prescriptions to increased dementia and MCI risks.
  • The drug suppresses communication between nerve cells, raising cognitive decline concerns, researchers said in background notes.
  • Patients prescribed gabapentin six or more times face a 29% higher dementia and 85% higher MCI risk, especially in adults aged 35–49, according to US scientists.
  • Healthcare providers are being advised to monitor cognition and consider physiotherapy or nerve blocks for middle-aged gabapentin users.
  • As an observational analysis, the study's design means no firm conclusions about causality can be drawn, and previous research has shown mixed results, highlighting ongoing debate.
Insights by Ground AI
Does this summary seem wrong?

24 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 90% of the sources are Center
90% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medscape broke the news in United States on Thursday, July 10, 2025.
Sources are mostly out of (0)